CANDEL THERAPEUTICS INC. - COMMON STOCK
5.7800
08-7月-24 15:59:42
15 分の遅延
株式
-0.0400
-0.69%
本日の幅
5.6200 - 6.0200
ISIN
N/A
ソース
NASDAQ
-
18 6 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Candel Therapeutics to Join Russell 3000® Index
11 6 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
FDA Grants Orphan Drug Designation for CAN-3110 for the Treatment of Recurrent High-Grade Glioma
30 5 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Candel Therapeutics to Present at the Jefferies Global Healthcare Conference
22 5 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
20 5 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Candel Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
14 5 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Candel Therapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting
25 4 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
11 4 2024 09:00:00 提供 Nasdaq GlobeNewswire
-
09 4 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
04 4 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
28 3 2024 08:05:47 提供 Nasdaq GlobeNewswire
-
05 3 2024 16:30:00 提供 Nasdaq GlobeNewswire
-
CAN-3110 Receives FDA Fast Track Designation for Treatment of Recurrent High-Grade Glioma
13 2 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
05 2 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Candel Therapeutics Receives FDA Fast Track Designation for CAN-2409 in Pancreatic Cancer
12 12 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Candel Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
09 11 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Candel Therapeutics Presents Preclinical Data from its enLIGHTEN™ Discovery Platform at SITC
04 11 2023 08:00:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >